SA Asks: What's the most attractive biotech stock right now?
Source: SeekingAlpha
2025-10-12 15:37:29 ET
More on BridgeBio Pharma, Immuneering
- BridgeBio Pharma, Inc. (BBIO) Presents at HFSA 2025 - Slideshow
- Immuneering Corporation (IMRX) Special Call - Slideshow
- Immuneering Corporation (IMRX) Discusses Phase 2a Data Update For IMM-1-104 In First-Line Pancreatic Cancer (Transcript)
- Immuneering surges 40% on mid-stage atebimetinib data in pancreatic cancer
- Immuneering announces public offering, $25M private placement with Sanofi; shares up 55%
Read the full article on Seeking Alpha
For further details see:
SA Asks: What's the most attractive biotech stock right now?
BridgeBio Pharma Inc.
NASDAQ: BBIO
BBIO Trading
0.73% G/L:
$71.995 Last:
353,151 Volume:
$71.54 Open:
BBIO Latest News
BBIO Stock Data
$13,905,867,946
157,635,809
2.34%
155
N/A
Biotechnology & Life Sciences
Healthcare
US
Palo Alto
